Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 8.68% vs -6.90% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 47.19% vs -41.70% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -1.16% vs -25.49% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 10.61% vs 11.86% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of HPGC Renmintongtai Pharmaceutical Corp. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 8.68% vs -6.90% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.17% vs 5.58% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 47.19% vs -41.70% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -44.49% vs -18.81% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -1.16% vs -25.49% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -46.94% vs -4.89% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 10.61% vs 11.86% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 32.73% vs 1.85% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






